⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7849269 | 1.00 | — | — | |
| SCHEMBL12240484 | 0.73 | — | — | |
| SCHEMBL4531053 | 0.73 | — | — | |
| SCHEMBL12240415 | 0.73 | — | — | |
| SCHEMBL13970265 | 0.71 | — | — | |
| SCHEMBL12266202 | 0.71 | — | — | |
| SCHEMBL6296159 | 0.71 | — | — | |
| SCHEMBL10597145 | 0.71 | — | — | |
| SCHEMBL21657357 | 0.71 | — | — | |
| SCHEMBL14791329 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102272111-A | 1,2 -thiazol yl derivatives as cannabinoid receptor ligands | — | 2011-12-07 | — | — | CN | disclosed |
| EP-1082323-A2 | OXAZOLIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | AstraZeneca UK Limited (GB) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999064417-A2 | OXAZOLIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ASTRAZENECA AB (SE) | 1999-12-16 | — | — | WO | disclosed |